{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-25-000047","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.260367+00:00","generated_at":"2026-05-22T07:32:02.684838+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"OrthoPediatrics Q1 revenue $52.4M (+17% YoY); raises FY2025 guidance to $236-242M","bullets":["Total Q1 revenue $52.4M (+17% YoY); U.S. revenue $40.9M (+19%), international $11.5M (+11%).","Net loss $10.7M ($0.46 per share) vs. $7.8M ($0.34) in Q1 2024; adjusted EBITDA loss improved to ($0.4M) from ($1.1M).","FY2025 revenue guidance raised to $236M-$242M (15-18% growth); adjusted EBITDA guidance reiterated at $15-17M.","Scoliosis revenue grew 34% to $13.7M; launched VerteGlide system for Early Onset Scoliosis.","Cash, equivalents and restricted cash $60.8M at quarter end vs. $70.8M at Dec 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-25-000047","json":"https://secwatch.observer/filing/0001425450-25-000047.json","markdown":"https://secwatch.observer/filing/0001425450-25-000047.md","text":"https://secwatch.observer/filing/0001425450-25-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/0001425450-25-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545025000047/kids-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:32:02.684838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}